This tool identifies patients with cardiovascular disease needing increased pharmaceutical care, suggesting better healthcare capacity management.
This stratification tool enables the identification of cardiovascular patients who require a higher level of pharmaceutical care, facilitating the adjustment of healthcare capacity. Validation of the model in a representative population is necessary to establish its broader applicability.
No takes yet. Share an insight, caveat, or question.
López et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: